CX DAILY

CX Daily: Chinese Biotech Is Having a ‘DeepSeek Moment’

Published: Jun. 17, 2025 9:20 a.m. GMT+8

00:00

00:00/00:00

Listen to this article 1x

TOP STORY

Drugs /

Cover Story: Chinese biotech is having a ‘deepseek moment’

In a resounding vote of confidence in China’s biotechnology sector, leading global pharmaceutical companies are striking multibillion-dollar deals for innovative therapies developed by Chinese firms. These deals mark a pivotal point for China’s role in global drug development and have sparked a capital market frenzy.

Register to read this article for free.

Register

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: Asia New Vision Forum Kicks Off in Singapore

NEWSLETTERS

Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription

PODCAST

Caixin Deep Dive: Former Securities Regulator Yi Huiman’s Corruption Probe

00:00

00:00/00:00

MOST POPULAR

1: Cover Story: Why Modi Won’t Play Cowboys and Indians With Trump, Opting Instead for Strategic Autonomy

2: China, U.S. to Meet in Spain Over TikTok, Trade Disputes

3: AI Offers Hope for Growth, but Global ‘Disorder’ Poses Major Risks, Lawrence Summers Says

4: Weekend Long Read: Tycoon’s Eight-Hour Escape Exposes Failings of a Model Chinese Prison

5: China Weighs Expanding Wealth Management Connect Beyond Greater Bay Area

SPONSORED

OR